Medroxyprogesterone-d3

• CAT Number: S000838
• CAS Number: 162462-69-3
• Molecular Formula: C22H29D3O3
• Molecular Weight: 347.51
• Purity: ≥95%
• Target: Progesterone Receptor
• IUPAC Name: (6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-6-(trideuteriomethyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
• InChI: InChI=1S/C22H32O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h12-13,16-18,25H,5-11H2,1-4H3/t13-,16+,17-,18-,20+,21-,22-/m0/s1/i1D3
• InChIKey: FRQMUZJSZHZSGN-ZLUPVJNASA-N
• SMILES: [2H]C([2H])([2H])[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C

Medroxyprogesterone-d3 is a high-purity, deuterium-labeled form of Medroxyprogesterone, a synthetic progestin and potent progesterone receptor agonist. This isotopically labeled compound, featuring three deuterium atoms, is integral to pharmaceutical research, particularly in studying drug metabolism, pharmacokinetics, and pharmacodynamics. The incorporation of stable heavy isotopes, like deuterium, enhances the precision of quantitative analysis in drug development. Deuteration can significantly impact the pharmacokinetic and metabolic profiles of drugs, making Medroxyprogesterone-d3 a valuable tool for researchers. This compound ensures reliable analytical results, aiding in the development of more effective and safer therapeutic agents